Trial Profile
Safety and efficacy of rivaroxaban and apixaban in patients with venous thrombosis of atypical location
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2016
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 26 Dec 2016 New trial record
- 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association